Cipher Pharmaceuticals (CPH) Stock Statistics & Valuation Metrics

Cipher Pharmaceuticals has a market cap or net worth of $333.10M. The enterprise value is C$276.07M.

Cipher Pharmaceuticals has 25,622,940 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cipher Pharmaceuticals’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 21.45%.

The current PE Ratio of Cipher Pharmaceuticals is 21.31. Cipher Pharmaceuticals’s PEG ratio is -0.83.

In the last 12 months, Cipher Pharmaceuticals had revenue of 33.36M and earned 11.54M in profits. Earnings per share was 0.46.

In the last 12 months, operating cash flow was 19.55M and capital expenditures -44.00K, giving a free cash flow of 19.50M billion.

Cipher Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Cipher Pharmaceuticals upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Cipher Pharmaceuticals as a current ratio of 1.94, with Debt / Equity ratio of 0.67%

In the past 12 months, Cipher Pharmaceuticals has paid -8.59M in taxes.

Cipher Pharmaceuticals EV to EBITDA ratio is 22.65, with an EV/FCF ratio of 13.78.

Cipher Pharmaceuticals has $17.84M in cash and marketable securities with $40.58M in debt, giving a net cash position of $22.74M billion.

Gross margin is 80.69%, with operating margin of 23.52%, and net profit margin of 34.60%.

The average price target for Cipher Pharmaceuticals is $15.01, which is 11.43% higher than the current price. The consensus rating is Moderate Buy